Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))

• (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print≤ 6% (with mirabegron)

Extrasystoles

• (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print (with mirabegron)

QT interval prolonged / QT prolongation

• (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print (with mirabegron)

QT interval shortening

• (2019): Katoh T+, Low Urin Tract Symptoms Sep, Epub ahead of print (with mirabegron)

Adverse effects / adverse reactions

• (2021): Yang N+, J Int Med Res Sep, Online ahead of print [REVIEW]